{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:15:32Z","timestamp":1791918932959,"version":"4.3.4"},"reference-count":58,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01CA251331"],"award-info":[{"award-number":["1R01CA251331"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HG012579"],"award-info":[{"award-number":["HG012579"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HG012076"],"award-info":[{"award-number":["HG012076"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,3,26]]},"abstract":"<jats:p>Relapse of acute myeloid leukemia (AML) is highly aggressive and often treatment refractory. We analyzed previously published AML relapse cohorts and found that 40% of relapses occur without changes in driver mutations, suggesting that non-genetic mechanisms drive relapse in a large proportion of cases. We therefore characterized epigenetic patterns of AML relapse using 26 matched diagnosis-relapse samples with ATAC-seq. This analysis identified a relapse-specific chromatin accessibility signature for mutationally stable AML, suggesting that AML undergoes epigenetic evolution at relapse independent of mutational changes. Analysis of leukemia stem cell (LSC) chromatin changes at relapse indicated that this leukemic compartment underwent significantly less epigenetic evolution than non-LSCs, while epigenetic changes in non-LSCs reflected overall evolution of the bulk leukemia. Finally, we used single-cell ATAC-seq paired with mitochondrial sequencing (mtscATAC) to map clones from diagnosis into relapse along with their epigenetic features. We found that distinct mitochondrially-defined clones exhibit more similar chromatin accessibility at relapse relative to diagnosis, demonstrating convergent epigenetic evolution in relapsed AML. These results demonstrate that epigenetic evolution is a feature of relapsed AML and that convergent epigenetic evolution can occur following treatment with induction chemotherapy.<\/jats:p>","DOI":"10.7554\/elife.93019","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T05:15:12Z","timestamp":1711516512000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.93019","source":"Crossref","is-referenced-by-count":43,"title":["Convergent epigenetic evolution drives relapse in acute myeloid leukemia"],"prefix":"10.7554","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2677-1319","authenticated-orcid":true,"given":"Kevin","family":"Nuno","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Biology Graduate Program, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Institute, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Division of Hematology, Stanford University School of Medicine","place":["Stanford, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1353-2060","authenticated-orcid":true,"given":"Armon","family":"Azizi","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Institute, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Division of Hematology, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/04gyf1771","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California Irvine School of Medicine","place":["Irvine, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Thomas","family":"Koehnke","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Institute, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Division of Hematology, Stanford University School of Medicine","place":["Stanford, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4179-4807","authenticated-orcid":true,"given":"Caleb","family":"Lareau","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Stanford University","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Program in Immunology, Stanford University","place":["Stanford, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"software","vocabulary":"credit"}]},{"given":"Asiri","family":"Ediriwickrema","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Biology Graduate Program, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Institute, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Division of Hematology, Stanford University School of Medicine","place":["Stanford, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"M Ryan","family":"Corces","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Biology Graduate Program, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Institute, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Division of Hematology, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/038321296","id-type":"ROR","asserted-by":"publisher"}],"name":"Gladstone Institute of Neurological Disease","place":["San Francisco, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"},{"role":"software","vocabulary":"credit"}]},{"given":"Ansuman T","family":"Satpathy","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Stanford University","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Program in Immunology, Stanford University","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Parker Institute for Cancer Immunotherapy, Stanford University","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/038321296","id-type":"ROR","asserted-by":"publisher"}],"name":"Gladstone-UCSF Institute of Genomic Immunology","place":["San Francisco, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5814-0984","authenticated-orcid":true,"given":"Ravindra","family":"Majeti","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Institute, Stanford University School of Medicine","place":["Stanford, United States"]},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Division of Hematology, Stanford University School of Medicine","place":["Stanford, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"4374","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","type":"journal-article","article-title":"ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression","volume":"22","author":"Abdel-Wahab","year":"2012","journal-title":"Cancer Cell"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","type":"journal-article","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Akbani","year":"2015","journal-title":"Cell"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41588-018-0270-1","type":"journal-article","article-title":"Subtype-specific regulatory network rewiring in acute myeloid leukemia","volume":"51","author":"Assi","year":"2019","journal-title":"Nature Genetics"},{"key":"bib4","type":"software","article-title":"Azizi\/Nuno eLife 2024","volume-title":"Software Heritage","author":"Azizi","year":"2024","unstructured":"Azizi A. 2024. Azizi\/Nuno eLife 2024. Software Heritage. swh:1:rev:f82a1cb04d6292ecdcf35c9e9c6d692c0fab84b2. https:\/\/archive.softwareheritage.org\/swh:1:dir:2cdb2d4fed638289596f0e0cc17894fe6883293d;origin=https:\/\/github.com\/armonazizi\/Azizi_Nuno_AML_Relapse_Chromatin;visit=swh:1:snp:3a59960d0af339b9bdbb24cb943cf916a08e4a53;anchor=swh:1:rev:f82a1cb04d6292ecdcf35c9e9c6d692c0fab84b2."},{"key":"bib5","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12185-013-1407-8","type":"journal-article","article-title":"Role of DNMT3A, TET2, and IDH1\/2 mutations in pre-leukemic stem cells in acute myeloid leukemia","volume":"98","author":"Chan","year":"2013","journal-title":"International Journal of Hematology"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","type":"journal-article","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nature Biotechnology"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","type":"journal-article","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.3646","type":"journal-article","article-title":"Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution","volume":"48","author":"Corces","year":"2016","journal-title":"Nature Genetics"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gde.2016.01.002","type":"journal-article","article-title":"The three-dimensional cancer genome","volume":"36","author":"Corces","year":"2016","journal-title":"Current Opinion in Genetics & Development"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","type":"journal-article","article-title":"An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues","volume":"14","author":"Corces","year":"2017","journal-title":"Nature Methods"},{"key":"bib11","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav1898","type":"journal-article","article-title":"The chromatin accessibility landscape of primary human cancers","volume":"362","author":"Corces","year":"2018","journal-title":"Science"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1073\/pnas.1324297111","type":"journal-article","article-title":"Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission","volume":"111","author":"Corces-Zimmerman","year":"2014","journal-title":"PNAS"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","type":"journal-article","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1349.001","type":"journal-article","article-title":"Acute myeloid leukemia stem cells","volume":"1044","author":"Dick","year":"2005","journal-title":"Annals of the New York Academy of Sciences"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature10738","type":"journal-article","article-title":"Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","type":"journal-article","article-title":"Acute Myeloid Leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1158\/2159-8290.CD-20-1375","type":"journal-article","article-title":"Chemotherapy induces senescence-like resilient cells capable of initiating aml recurrence","volume":"11","author":"Duy","year":"2021","journal-title":"Cancer Discovery"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature16490","type":"journal-article","article-title":"Insulator dysfunction and oncogene activation in IDH mutant gliomas","volume":"529","author":"Flavahan","year":"2016","journal-title":"Nature"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s41587-019-0332-7","type":"journal-article","article-title":"Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia","volume":"37","author":"Granja","year":"2019","journal-title":"Nature Biotechnology"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41588-021-00790-6","type":"journal-article","article-title":"ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis","volume":"53","author":"Granja","year":"2021","journal-title":"Nature Genetics"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1158\/1078-0432.CCR-17-2344","type":"journal-article","article-title":"Evolution of cytogenetically normal acute myeloid leukemia during therapy and relapse: an exome sequencing study of 50 patients","volume":"24","author":"Greif","year":"2018","journal-title":"Clinical Cancer Research"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.20092506","type":"journal-article","article-title":"Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations","volume":"207","author":"Gross","year":"2010","journal-title":"The Journal of Experimental Medicine"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.exphem.2017.07.002","type":"journal-article","article-title":"Genetic and epigenetic heterogeneity and the impact on cancer relapse","volume":"54","author":"Hassan","year":"2017","journal-title":"Experimental Hematology"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1126\/science.aad9024","type":"journal-article","article-title":"Activation of proto-oncogenes by disruption of chromosome neighborhoods","volume":"351","author":"Hnisz","year":"2016","journal-title":"Science"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1182\/blood-2016-02-695312","type":"journal-article","article-title":"Evolution of acute myelogenous leukemia stem cell properties after treatment and progression","volume":"128","author":"Ho","year":"2016","journal-title":"Blood"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1101\/gad.284109.116","type":"journal-article","article-title":"Epigenetics of hematopoiesis and hematological malignancies","volume":"30","author":"Hu","year":"2016","journal-title":"Genes & Development"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1073\/pnas.1100551108","type":"journal-article","article-title":"Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker","volume":"108","author":"Jan","year":"2011","journal-title":"PNAS"},{"key":"bib28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004315","type":"journal-article","article-title":"Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia","volume":"4","author":"Jan","year":"2012","journal-title":"Science Translational Medicine"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.beha.2006.10.005","type":"journal-article","article-title":"The leukemic stem cell","volume":"20","author":"Jordan","year":"2007","journal-title":"Best Practice & Research. Clinical Haematology"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","type":"journal-article","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Koboldt","year":"2012","journal-title":"Nature"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","type":"journal-article","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Research"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/ng.2731","type":"journal-article","article-title":"Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms","volume":"45","author":"Kon","year":"2013","journal-title":"Nature Genetics"},{"key":"bib33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw227","type":"journal-article","article-title":"VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research","volume":"44","author":"Lai","year":"2016","journal-title":"Nucleic Acids Research"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41587-020-0645-6","type":"journal-article","article-title":"Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling","volume":"39","author":"Lareau","year":"2021","journal-title":"Nature Biotechnology"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","type":"journal-article","article-title":"DNMT3A mutations in acute myeloid leukemia","volume":"363","author":"Ley","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","type":"journal-article","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","type":"journal-article","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/nm.4125","type":"journal-article","article-title":"Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia","volume":"22","author":"Li","year":"2016","journal-title":"Nature Medicine"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1158\/2159-8290.CD-19-1128","type":"journal-article","article-title":"Noncoding variants connect enhancer dysregulation with nuclear receptor signaling in hematopoietic malignancies","volume":"10","author":"Li","year":"2020","journal-title":"Cancer Discovery"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1158\/2159-8290.CD-17-0399","type":"journal-article","article-title":"Superenhancer analysis defines novel epigenomic subtypes of Non-APL AML, including an RAR\u03b1 dependency targetable by SY-1425, a potent and selective RAR\u03b1 agonist","volume":"7","author":"McKeown","year":"2017","journal-title":"Cancer Discovery"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1182\/blood-2012-04-427039","type":"journal-article","article-title":"Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia","volume":"121","author":"Parkin","year":"2013","journal-title":"Blood"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1172\/JCI91964","type":"journal-article","article-title":"Ultrasensitive mutation detection identifies rare residual cells causing acute myelogenous leukemia relapse","volume":"127","author":"Parkin","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nri2024","type":"journal-article","article-title":"Transcription factors in myeloid development: balancing differentiation with transformation","volume":"7","author":"Rosenbauer","year":"2007","journal-title":"Nature Reviews. Immunology"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/s41375-018-0034-z","type":"journal-article","article-title":"Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia","volume":"32","author":"Rothenberg-Thurley","year":"2018","journal-title":"Leukemia"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/s41590-022-01327-7","type":"journal-article","article-title":"Clonal expansion and epigenetic inheritance of long-lasting NK cell memory","volume":"23","author":"R\u00fcckert","year":"2022","journal-title":"Nature Immunology"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature13038","type":"journal-article","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature22993","type":"journal-article","article-title":"Tracing the origins of relapse in acute myeloid leukaemia to stem cells","volume":"547","author":"Shlush","year":"2017","journal-title":"Nature"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1182\/bloodadvances.2020003709","type":"journal-article","article-title":"Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets","volume":"5","author":"Stratmann","year":"2021","journal-title":"Blood Advances"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1158\/2159-8290.CD-20-1274","type":"journal-article","article-title":"Nongenetic evolution drives lung adenocarcinoma spatial heterogeneity and progression","volume":"11","author":"Tavernari","year":"2021","journal-title":"Cancer Discovery"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","type":"journal-article","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"The Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","type":"journal-article","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"The Cancer Genome Atlas Research Network","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","type":"journal-article","article-title":"Biology and relevance of human acute myeloid leukemia stem cells","volume":"129","author":"Thomas","year":"2017","journal-title":"Blood"},{"key":"bib53","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1644","type":"journal-article","article-title":"The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity","volume":"353","author":"Torres","year":"2016","journal-title":"Science"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","type":"journal-article","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s43018-020-00114-3","type":"journal-article","article-title":"Illuminating the noncoding genome in cancer","volume":"1","author":"Zhang","year":"2020","journal-title":"Nature Cancer"},{"key":"dataset1","type":"dataset","article-title":"Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia","volume-title":"NCBI Gene Expression Omnibus","author":"Nuno","year":"2024","unstructured":"Nuno KA, Azizi A, K\u00f6hnke T, Lareau CA, Ediwirickrema A, Corces MR, Satpathy AT, Majeti R. 2024. Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia. NCBI Gene Expression Omnibus. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE256495. GSE256495."},{"key":"dataset2","type":"dataset","article-title":"ATAC-seq data","volume-title":"NCBI Gene Expression Omnibus","author":"Buenrostro","year":"2016","unstructured":"Buenrostro J. 2016. ATAC-seq data. NCBI Gene Expression Omnibus. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE74912. GSE74912."},{"key":"dataset3","type":"dataset","article-title":"Single-cell, multi-omic analysis identifies regulatory programs in mixed phenotype acute leukemia","volume-title":"NCBI Gene Expression Omnibus","author":"Granja","year":"2019","unstructured":"Granja JM. 2019. Single-cell, multi-omic analysis identifies regulatory programs in mixed phenotype acute leukemia. NCBI Gene Expression Omnibus. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE139369. GSE139369."}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/93019\/elife-93019-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/93019\/elife-93019-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/93019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:34:48Z","timestamp":1787567688000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/93019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":58,"alternative-id":["10.7554\/eLife.93019"],"URL":"https:\/\/doi.org\/10.7554\/elife.93019","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.10.561642","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2023.10.10.561642","asserted-by":"object"}],"references":[{"id-type":"accession","id":"GSE74912","asserted-by":"subject"},{"id-type":"accession","id":"GSE139369","asserted-by":"subject"}],"is-supplemented-by":[{"id-type":"accession","id":"GSE256495","asserted-by":"subject"},{"id-type":"uri","id":"https:\/\/archive.softwareheritage.org\/swh:1:dir:2cdb2d4fed638289596f0e0cc17894fe6883293d;origin=https:\/\/github.com\/armonazizi\/Azizi_Nuno_AML_Relapse_Chromatin;visit=swh:1:snp:3a59960d0af339b9bdbb24cb943cf916a08e4a53;anchor=swh:1:rev:f82a1cb04d6292ecdcf35c9e9c6d692c0fab84b2","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.93019.sa2","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.93019.sa1","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.93019.sa0","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e93019"}}